Evaluation of the Pharmacokinetics and Pharmacodynamics of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infections Using Data from Two Phase 2 Clinical Studies

The pharmacokinetic-pharmacodynamic (PK-PD) relationships between serum exposure measures of liposomal amikacin for inhalation (LAI) and the change in pulmonary function test (PFT) measures and number of CFU from baseline were evaluated in cystic fibrosis (CF) patients chronically infected with Pseu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Okusanya, Olanrewaju O., Bhavnani, Sujata M., Hammel, Jeffrey P., Forrest, Alan, Bulik, Catharine C., Ambrose, Paul G., Gupta, Renu
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2014
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4135881/
https://ncbi.nlm.nih.gov/pubmed/24687506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02421-13
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires